Paid Clinical Trials Cleveland

Discover 1,495 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,495

RinSe DeviceEfficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study

Recruiting

Sponsor:

The Cleveland Clinic

Location:

Cleveland OH

Code:

NCT06193512

Conditions

Oral Bacterial Infection

Mechanical Ventilation Complication

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SwishKit + Oral care treatment as usual

Oral care treatment as usual

TIRzepatideTIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Recruiting

PHASE2

Sponsor:

The Cleveland Clinic

Location:

Cleveland OH

Code:

NCT06802081

Conditions

Atrial Fibrillation

Obesity

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Placebo

Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Recruiting

Sponsor:

Axogen Corporation

Location:

Cleveland OH, Columbus OH, Toronto, Cincinnati OHshow 33 more

Code:

NCT01526681

Conditions

Peripheral Nerve Injuries

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Processed Human Nerve Graft

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Autogenous Nerve Graft

Nerve Tube Conduit

Autologous Breast Reconstruction with Neurotization

BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

BicycleTx Limited

Location:

Cleveland OH, Toronto, Lafayette IN, Louisville KYshow 10 more

Code:

NCT04561362

Conditions

Urinary Bladder Neoplasm

Triple Negative Breast Neoplasms

Hormone Receptor Positive, HER2-negative Neoplasms

Hormone Receptor Positive, HER2-low Neoplasms

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BT8009

Pembrolizumab

PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Cleveland OH, Detroit MI, Farmington Hills MI, Torontoshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

BIIB091 & DRFA Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting

PHASE2

Sponsor:

Biogen

Location:

Cleveland OH, Columbus OH, Fort Wayne IN, Cincinnati OHshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

HBI-2438A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

Recruiting

PHASE1

Sponsor:

HUYABIO International, LLC.

Location:

Canton OH, Farmington Hills MI, Kansas City MO, Plantation FLshow 8 more

Code:

NCT05485974

Conditions

Lung Cancer

Non Small Cell Lung Cancer

Colorectal Cancer

Cancer of Pancreas

Colon Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HBI-2438

Single vs. MultipleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Cleveland OH, Royal Oak MI, London, Zanesville OHshow 45 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

Talquetamab, Daratumumab, PomalidomideA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Cleveland OH, Ann Arbor MI, Columbus OH, Charlottesville VAshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Cleveland OH, Westlake OH, Clinton Township MI, Ypsilanti MIshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo